Ageing is a complex biological process associated with increased morbidity and mortality.
Nine classic, interdependent hallmarks of ageing have been proposed involving genetic and …

Sarcopenic obesity is characterized by a concurrent decline in muscle mass and function,
along with increased adipose tissue. Sarcopenic obesity is a growing concern in older …

Aging, a universal and inevitable process, is characterized by a progressive accumulation of
physiological alterations and functional decline over time, leading to increased vulnerability …

Sarcopenia is an age-related clinical complaint characterized by the progressive
deterioration of skeletal muscle mass and strength over time. Type 2 diabetes (T2D) is …

Background Sarcopenia, the age‐related loss of muscle mass and function, brings multiple
adverse outcomes including disability and death. Several sarcopenia consensuses have …

Sarcopenia is a chronic degenerative disease affecting primarily older adults. A growing
aging population is gradually increasing the number of patients suffering from sarcopenia …

Loss of skeletal muscle strength and mass (sarcopenia) is common in older adults and
associated with an increased risk of disability, frailty and premature death. Finding cost …

Background Sarcopenia is a progressive, systemic skeletal muscle disorder. Resistance
exercise and physical activity have been proven effective in its treatment, but consensus on …

Sarcopenia is a systemic skeletal muscle disease characterized by a decline in skeletal
muscle mass and function. Originally defined as an age‐associated condition, sarcopenia …

Sarcopenia is the loss of muscle mass and function from aging, inactivity, or disuse. It is a
comorbidity to numerous conditions that exacerbates their severity and adversely impacts …